video1.0<iframe src="https://www.loom.com/embed/10ede61433a844b8a3790a221a7c7bbc" frameborder="0" width="1382" height="1036" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>10361382Loomhttps://www.loom.com10361382https://cdn.loom.com/sessions/thumbnails/10ede61433a844b8a3790a221a7c7bbc-0e617c01fde95ebf.gif227.399In this video, I discuss our innovative approach to treating diseases like Phenylketonuria (PKU) using red blood cells that contain "enzyme CARGO". We have established a master cell bank, with 80% cells maturing into therapeutic red blood cells. Our decentralized manufacturing strategy allows us to serve markets in the USA, European Union and Japan effectively. I also highlight the market potential of USA and EU combine valued at approximately USD 9 billion annually. Please take a moment to review this information and let me know your thoughts.